首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Inflammatory Bowel Diseases

Inflammatory Bowel Diseases杂志,由Oxford University Press出版,于1995年创刊,Monthly,出版语言English,ISSN:1078-0998,E-ISSN:1536-4844。

投稿咨询
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.5
CiteScore
9.2
期刊收录
SCI、SCIE

Inflammatory Bowel Diseases(中文译名:《炎症性肠病》),ISSN:1078-0998,EISSN:1536-4844,是Oxford University Press出版的国际性学术期刊,创刊于1995年,以Monthly形式稳定发行,2026年总发文量约221篇。该刊采用非OA开放访问,学科归属为医学 - 胃肠肝病学。该刊是医学、胃肠肝病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.5,2025年期刊CiteScore为9.2,2025年期刊自引率约5.5%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Inflammatory Bowel Diseases长期聚焦医学、胃肠肝病学及相关产业的技术应用前沿,平均审稿周期约1月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、胃肠肝病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACanada、Italy、CHINA MAINLAND、England、Netherlands、Australia等为核心发文国家与地区;HARVARD UNIVERSITYCLEVELAND CLINIC FOUNDATION、ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI、UNIVERSITY OF CALIFORNIA SYSTEM、MAYO CLINIC、UNIVERSITY OF NORTH CAROLINA、UNIVERSITY OF PENNSYLVANIA等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 30 / 153

80.7

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 35 / 153

77.45

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 30 / 148

80.1

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 33 / 148

78.04


中国学者近期发文

1
The morphology paradox in pediatric IBD organoids: a path from transcriptomic heterogeneity to clinical utilit

Author:Qi, Linfan; Wu, Zijian; Cai, Hui

Journal: INFLAMMATORY BOWEL DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1093/ibd/izag049

2
Development and validation of a predictive model for early failure of biological therapy in perianal fistulizing Crohn's disease based on three-dimensional transrectal ultrasoun

Author:Ding, Shi-Si; Liu, Chang; Zhang, Guan-Qun; Ren, Wei-Wei; Zhao, Hui; Zhang, Qian; Yin, Hao-Qiang; Sun, Li-Ping; Xu, Hui-Xiong

Journal: INFLAMMATORY BOWEL DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1093/ibd/izag048

3
Mesenchymal stem cell-derived exosomes derived from induced pluripotent stem cells ameliorate inflammation and promote mucosal healing via miR-34a-5p in Crohn diseas

Author:Feng, Ting; Qiu, Yun; Chen, Baili; Huang, Xuanzhi; Feng, Rui; He, Yao; Zeng, Zhirong; Chen, Minhu; Zhang, Shenghong

Journal: INFLAMMATORY BOWEL DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1093/ibd/izag014

4
A methodological concern regarding small-sample propensity score matching and overfitting in the study of postoperative biologic strategies for Crohn's diseas

Author:Xia, Jiajia; Zhang, Yingzhe

Journal: INFLAMMATORY BOWEL DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1093/ibd/izag024

5
Letter to the editor: enhancing the robustness of early vs late switch to subcutaneous infliximab in inflammatory bowel disease (IBD): the value of propensity score analysi

Author:Shi, Huiyang; Zhang, Shengdi; Peng, Yu

Journal: INFLAMMATORY BOWEL DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1093/ibd/izag033

6
Impact of visceral adipose tissue and skeletal muscle on early and long-term biologic treatment failure in Crohn's disease: A multicenter retrospective cohort stud

Author:Guo, Qiong; Wang, Quanrongzi; Chen, Jie; Lu, Meijiao; Zhao, Xiaojing; Ma, Jingjing; Jiao, Chunhua; Tang, Nana; Zhang, Hongjie

Journal: INFLAMMATORY BOWEL DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1093/ibd/izag023

7
Electroacupuncture at Baliao Points Alleviates Ulcerative Colitis via α7nAChR-Mediated Macrophage Polarization and Gut Microbiota Modulatio

Author:Liu, Xue; Gao, Jiang-Bo; Li, Wen-Xuan; Xu, Chen-Yi; Zhang, Zhi-Yuan; Yang, Xu; Ni, Min

Journal: INFLAMMATORY BOWEL DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1093/ibd/izaf321

8
Reply: A methodological concern regarding small-sample propensity score matching and overfitting in the study of postoperative biologic strategies for Crohn's diseas

Author:Zhang, Chunjie; Li, Yi

Journal: INFLAMMATORY BOWEL DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1093/ibd/izag025

9
Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn's Disease and Ulcerative Coliti

Author:Gan, Xiaoqin; Zhang, Yanjun; Zhang, Yuanyuan; Ye, Ziliang; Yang, Sisi; Xiang, Hao; Huang, Yu; Wu, Yiting; Zhang, Yiwei; Qin, Xianhui

Journal: INFLAMMATORY BOWEL DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1093/ibd/izaf325

10
Pou2af1 Deficiency Aggravates DSS-Induced Colitis via Impaired Germinal Center Responses and Altered Gut Microbiot

Author:Huang, Jijun; Liang, Wenting; Zhang, Ruizhi; Zhao, Yuyang; Shi, Rong; Chen, Xiangming; Zheng, Yanling; Li, Xiaomin; Liu, Donglian; Wang, Haoyang; Liu, Jiamin; Liao, Yue; Zhang, Xinqi; Jiang, Zhihan; Fu, Cheng; Huang, Ting; Shan, Xiaokang; Wang, Wanlin; Bu, Jin; Peng, Tieli; Shen, Erxia

Journal: INFLAMMATORY BOWEL DISEASES. 2025; Vol. , Issue , pp. -. DOI: 10.1093/ibd/izaf089


在线咨询

Inflammatory Bowel Diseases

国际简称:INFLAMM BOWEL DIS参考译名:炎症性肠病

年发文量:221 CiteScore:9.2 是否预警:否 Gold OA文章占比:28.53% 研究类文章占比:88.24%

杂志社联系方式:JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030

Inflammatory Bowel Diseases